upcoming glp-1 drugs What is the pipeline for future medications for obesity? 6 Things to Know About

injection it is absorbed over 1-3 days with a steady state plasma level being achieved after 4-5 weeks of weekly dosing

In Phase 3 trials, more than half of patients lost over 10% of their body weight in 6 months

Hendarto et

(2), with pGCG = plasma glucagon level, k = slope of the regression line at baseline of SUV 55min (SUV 55min, Baseline ) over plasma glucagon (pGCG Baseline ) Estimation of slope k was based on all n = 13 subjects for whom SUV 55min and plasma glucagon values were available at baseline

therefore, adopting strategies to minimize muscle and bone loss is prudent

"GLP-1 medications represent the chance for a breakthrough in obesity treatment, but to unlock this potential, more patients need access to them plus the care and coaching that makes treatment most effective